Snowball logo
logo
4157

Taigen Biopharmaceuticals Holdings Ltd

4157 β€’ TWO
NT$9.13NT$0.00Β  (0%)
πŸ’‘ Click on a row in the table to make it appear on the graph
πŸ“Š Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20212022202320242025TTM
Revenue
Total revenue
1,294.536.23123.1150.7259.5258.9
COGS
12.723.73639.0516.1318.1717.16
Gross Profit
1,281.832.4984.08134.5241.3241.8
Operating Expenses & Income
Operating Income
876.2(217.2)(174.7)(122.1)69.3975.49
Total Operating Expenses
382.3310.2258.8272.7190.1183.4
R&D Expenses
283.3237.5187.5166.196.8891.23
Selling General & Admin Expenses
99.0672.6498.990.5575.0275.05
Earnings from Continuing Operations
Interest Expense
(0.244)(0.854)(1.137)(1.424)(1.665)(1.43)
Interest Income
4.2298.72320.3824.418.4715.95
Income Tax Expense
100.47.3996.756---
Net Income
Net Income
775.6(237.2)136.7(38.58)45.1853.51
Supplemental
EBIT
876.2(217.2)(174.7)---
EBITDA
905.1(188.6)(147.1)---
In millions of TWD, except % and values per 1 share